Patients with common variable immunodeficiency (CVID) requiring IV immunoglobulin (IVIG) therapy have poorer health-related (HR) QOL than individuals with other chronic diseases

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.461, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID)

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 4, 2017-11 ,pp. : 332-340

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 688-690

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease: An Open-Label Prospective Study

By Kasztalska Karolina  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 299-307

Adis International

Access to resources Recommend Favorite

Laughter therapy provided substantial improvements in health-related quality of life among patients requiring haemodialysis

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

IV immunoglobulin (IVIG) is a valid maintenance therapy option for myasthenia gravis

By  

Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite